For the quarter ended March 2026, Ryan Specialty Group (RYAN Quick QuoteRYAN - Free Report) reported revenue of $795.23 million, up 15.2% over the same period last year. EPS came in at $0.47, compared to $0.39 in the year-ago quarter.

The reported revenue represents a surprise of +3.44% over the Zacks Consensus Estimate of $768.79 million. With the consensus EPS estimate being $0.43, the EPS surprise was +8.67%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Ryan Specialty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Fiduciary investment income: $12.33 million versus the three-analyst average estimate of $12.49 million.
• Revenue- Net commissions and fees: $782.9 million versus $756.31 million estimated by three analysts on average.
• Revenue- Net commissions and fees- Binding Authority: $110 million versus $110.37 million estimated by two analysts on average.
• Revenue- Net commissions and fees- Underwriting Management: $295.11 million versus the two-analyst average estimate of $255.22 million.
• Revenue- Net commissions and fees- Wholesale Brokerage: $377.8 million versus the two-analyst average estimate of $383.34 million.

View all Key Company Metrics for Ryan Specialty here>>>

Shares of Ryan Specialty have returned +6.8% over the past month versus the Zacks S&P 500 composite's +12.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.